Beyond our hypothesis, effects of treatment were clearly multifactorial and, in part, appeared to be associated with an increased expansion of VAT involving the modulation of growth factors such as IGF1 and FGF1, ECM organization through TIMP4, and lipidosis. This evidence concerns the gene FGF1 and lysosomal lipid storage disorder.